EIN 32-0067668

Cystinosis Research Foundation

IRS 501(c) type
501(c)(3)
Num. employees
1
City
Year formed
2003
Most recent tax filings
2020-06-01
Description
The Cystinosis Research Foundation's mission is to support bench,clinical and translational Cystinosis Research for better treatments and a cure. Crf has been instrumental in establishing a global patient registry to help accelerate Cystinosis Researc...

Program areas at Cystinosis Research Foundation

"NATALIE'S WISH"NATALIE'S WISH, 'TO HAVE MY DISEASE GO AWAY FOR EVER' - THOSE SEVEN WORDS PROVIDED THE INSPIRATION TO ESTABLISH THE CYSTINOSIS RESEARCH FOUNDATION (CRF) IN 2003. WE KNEW AT THAT MOMENT THAT WE NEEDED TO MAKE EVERY EFFORT TO MAKE NATALIE'S WISH - AND THE WISH OF OTHERS WITH CYSTINOSIS - A REALITY.RESEARCHTHE CYSTINOSIS RESEARCH FOUNDATION IS DEDICATED TO FINDING BETTER TREATMENTS TO IMPROVE THE QUALITY OF LIFE FOR THOSE WITH CYSTINOSIS AND TO ULTIMATELY FIND A CURE FOR THIS DEVASTATING DESEASE. CRF IS COMMITED TO FINDING A CURE THROUGH AN AGGRESSIVELY FUNDED RESEARCH AGENDA. CRF AWARDS RESEARCH GRANTS BI-ANNUALLY TO ACCELERATE THE RESEARCH PROCESS AND TO ENSURE THAT THERE IS NEVER A GAP IN FUNDING NEW CUTTING-EDGE RESEARCH PROJECTS. CRF IS DEDICATED TO IMPROVING THE QUALITY OF LIFE FOR CYSTINOSIS PATIENTS AND TO FINDING BETTER TREATMENTS, INCLUDING A CURE, FOR OUR ADULTS AND CHILDREN LIVING WITH CYSTINOSIS.EDUCATIONTHE CYSTINOSIS RESEARCH FOUNDATION IS DEDICATED TO EDUCATING THE CYSTINOSIS COMMUNITY, THE PUBLIC AND THE MEDICAL COMMUNITY ABOUT CYSTINOSIS TO ENSURE EARLY DIAGNOSIS AND IMMEDIATE AND PROPER TREAMENT. HISTORY AND RESEARCHCYSTINOSIS IS A RARE, METABOLIC, GENETIC DISEASE THAT AFFLICTS APPROXIMATELY 2,000 CHILDREN AND ADULTS WORLDWIDE. CRF IS INCREASINGLY FOCUSED ON FUNDING CLINICAL AND TRANSLATIONAL RESEARCH WHICH IS CRUCIAL TO FINDING NEW TREATMENTS AND A CURE FOR CYSTINOSIS. CRF IS COMMITTED TO PRIORITIZING AND AGGRESSIVELY SUPPORTING RESEARCH THAT HAS THE POTENTIAL TO SIGNIFICANTLY IMPROVE THE QUALITY OF LIFE FOR CHILDREN AND ADULTS WITH CYSTINOSIS. RESEARCH GIVES US HOPEWE FIRMLY BELIEVE THAT FUNDING AND SUPPORTING RESEARCH GIVES US HOPE FOR A BRIGHTER FUTURE FOR THOSE LIVING WITH CYSTINOSIS.HOPE ALLOWS US TO LIVE WITH CYSTINOSIS UNTIL THE DAY A CURE IS FOUND. SINCE 2003, THE CYSTINOSIS RESEARCH FOUNDATION (CRF)HAS BECOME THE LARGEST FUND PROVIDER OF CYSTINOSIS RESEARCH IN THE WORLD RAISING MORE THAN $55 MILLION FROM DONORS ALL OVER THE WORLD. BY STRATEGICALLY AND AGGRESSIVELY INVESTING MILLIONS OF DOLLARS INTO CYSTINOSIS RESEARCH. CRF HAS CREATED A THRIVING AND COLLABORATIVE RESEARCH COMMUNITY AND HAS CHANGED THE COURSE OF CYSTINOSIS. FROM THE START OF THE FOUNDATION ALL CRF OPERATING COSTS HAVE BEEN PRIVATELY UNDERWRITTEN SO THAT 100 PERCENT OF THE FUNDS DONATED TO CRF ARE USED TO SUPPORT CYSTINOSIS RESEARCH.WE ARE PLEASED TO ANNOUNCE THAT DURING THE 12 MONTHS PERIOD ENDING JUNE 30,2020, CRF AWARDED 24 NEW GRANTS, EXTENSION GRANTS AND EQUIPMENT GRANTS TOTALING MORE THAN $5 MILLION FOR CYSTINOSIS RESEARCH. THE NEW GRANTS BRING US THAT MUCH CLOSER TO BETTER TREATMENTS AND A CURE. CRF AWARDS GRANTS TO THE BEST AND BRIGHTEST RESEARCHERS IN THE WORLD. TO DATE, CRF HAS FUNDED 200 STUDIES AT LEADING RESEARCH INSTITUTIONS IN 12 COUNTRIES. CRF-FUNDED RESEARCHERS HAVE PUBLISHED 86 ARTICLES IN PRESTIGIOUS, TOP-RATED JOURNALS. THOSE ARTICLES, AVAILABLE TO EVERYONE IN THE WORLD, HAVE CONTRIBUTED TO THE UNDERSTANDING OF THE PATHOGENESIS AND TREATMENT OF CYSTINOSIS.RESEARCH PROGRESSFROM THE START OF THE FOUNDATION,WE HAVE UNDERSTOOD THAT FUNDING BASIC AND BENCH RESEARCH WAS IMPORTANT TO UNDERSTANDING CYSTINOSIS.OVER THE YEARS, AS DISCOVERIES WERE MADE IN THE LAB, CRF BEGAN FUNDING CLINICAL RESEARCH, AND NOW WE ARE TRANSLATING THE DATA FROM THE CLINICAL STUDIES TO THE PATIENTS. OUR STRATEGY OF PROVIDING SEED MONEY TO TALENTED RESEARCHERS HAS BEEN SUCCESSFUL. OUR FIRST PROJECT INVOLVED FUNDING RESEARCHERS WHO WERE FOCUSED ON A NEW TREATMENT. CRF PROVIDED GRANTS THAT FUNDED EVERY BENCH AND CLINICAL TRIAL THAT LED TO THE DISCOVERY OF A DELAYED-RELEASE FORM OF THE LIFE-SAVING MEDICATION FOR CYSTINOSIS. THAT MEDICATION, PROCYSBI WAS APPROVED BY THE FDA ON APRIL 30, 2013, AND IS CONSIDERED THE MOST SIGNIFICANT ADVANCEMENT IN THE TREATMENT OF CYSTINOSIS IN 30 YEARS. IN 2007, CRF BEGAN FUNDING DR. STEPHANIE CHERQUI, AT UC SAN DIEGO WHO WAS FOCUSED ON STEM CELL AND GENE THERAPY RESEARCH. AS A DIRECT RESULT OF CRF'S EARLY FUNDING AND CONTINUOUS FUNDING THROUGHOUT THE YEARS, IN DECEMBER 2018, THE FDA APPROVED A CLINICAL TRIAL TO TEST THE EFFICACY AND SAFETY OF A STEM CELL AND GENE THERAPY TREATMENT FOR CYSTINOSIS PATIENTS. IN OCTOBER 2019, THE FIRST CYSTINOSIS PATIENT WAS TRANSPLANTED AND IN JUNE, 2020, THE SECOND PATIENT WAS TRANSPLANTED WITH THE TREATMENT. CRF'S GRANTS TO DR. CHERQUI HAVE BEEN LEVERAGED BY MULTI-MILLION-DOLLAR GRANTS FROM OTHER FUNDING AGENCIES. IF THIS TREATMENT WORKS, IT COULD STOP THE PROGRESSION OF CYSTINOSIS OR BE THE CURE FOR CYSTINOSIS.SINCE CYSTINOSIS IS A SYSTEMIC DISEASE AND EVERY TISSUE IS AFFECTED, CRF HAS TARGETED MULTIPLE AREAS OF RESEARCH TO FUND INCLUDING MUSCLE WASTING, NEUROLOGICAL ISSUES, CORNEAL CYSTINOSIS, AND STEM CELL AND GENE THERAPY, ALL WITH THE GOAL OF FINDING BETTER TREATMENTS AND A CURE FOR CYSTINOSIS.CYSTINOSIS RESEARCH HELPS OTHERSMany of the discoveries made by CRF researchers are currently being applied to other more prevalent and well-known disorders and diseases including other corneal diseases, kidney diseases and genetic and systemic diseases similar to cystinosis. Support for cystinosis research has reached far beyond the cystinosis community. A cure for cystinosis will help find cures for other diseases potentially helping millions of people. CRF FAMILIES AND PARTNERSThe Cystinosis Research Foundation has witnessed tremendous growth OVER THE YEARS AS CYSTINOSIS FAMILIES HAVE JOINED OUR FUNDRAISING EFFORTS. PEOPLE FROM ALL OVER THE WORLD HAVE embraced the cystinosis cause and enthusiastically raiseD funds to support cystinosis research through CRF. We have found strength in numbers and our joint effort gives us a renewed sense of community and purpose.DAY OF HOPE CONFERENCEEach year the Cystinosis Research Foundation hosts the Day of Hope Family Conference. In 2019, 66 families from around the world gathered to share stories, hopes and dreams and build life-long friendships. Leading CRF FUNDED RESEARCHERS ATTENDED THE CONFERENCE AND UPDATED THE CYSTINOSIS COMMUNITY ON THEIR RESEARCH PROGRESS INCLUDING UPDATES ON GENE AND STEM CELL THERAPIES, NOVEL EYE REASEARCH AND NEUROLOGICAL RESEARCH. THE CONFERENCE EDUCATES CYSTINOSIS FAMILIES ABOUT THE CURRENT AND ONGOING RESEARCH AND OFFERS THEM HOPE THAT BRIGHTER DAYS ARE AHEAD FOR CYSTINOSIS PATIENTS.CURE CYSTINOSIS INTERNATIONAL REGISTRYTHE CYSTINOSIS RESEARCH FOUNDATION IS EXCITED TO ANNOUNCE THAT A NEW, UPDATED REGISTRY, THE CURE CYSTINOSIS INTERNATIONAL REGISTRY (CCIR) WILL BE LAUNCHED IN THE FALL OF 2020. THE PATIENT REGISTRY WILL BE A VAST IMPROVEMENT OVER THE PREVIOUS REGISTRY. THE NEW REGISTRY WILL TRACK PATIENTS' NATURAL HISTORY DATA, COLLECT DATA ABOUT CURRENT TREATMENTS, IDENTIFY KNOWN AND UNKNOWN MEDICAL COMPLICATIONS AND COLLECT INFORMATION ABOUT QUALITY OF LIFE ISSUES. THE CCIR WILL BE A CENTRAL HUB OF INFORMATION FOR THE GLOBAL COMMUNITY. THE DEIDENTIFIED PATIENT DATA FROM THE REGISTRY CAN BE SHARED WITH CYSTINOSIS CLINICIANS, RESEARCHERS AND SCIENTISTS WHO ARE PURSUING RESEARCH FOCUSED ON BETTER TREATMENTS AND A CURE FOR CYSTINOSIS. CRF INTERNATIONAL RESEARCH SYMPOSIUMCRF'S INTERNATIONAL RESEARCH SYMPOSIUM IS HELD EVERY TWO YEARS AND IS A HIGHLIGHT FOR CYSTINOSIS RESEARCHERS. ATTENDEES ARE CRF FUNDED RESEARCHERS AND SCIENTISTS FROM AROUND THE WORLD.APPROXIMATELY 65 CYSTINOSIS EXPERTS FROM LEADING INTERNATIONAL UNIVERSITIES AND RESEARCH INSTITUTIONS ARE INVITED TO GIVE PRESENTATIONS ABOUT THEIR WORK. ATTENDEES SHARE THEIR RESEARCH PROGRESS AND ARE ENCOURAGED TO FORM COLLABORATIONS IN AN EFFORT TO ACCELERATE THE RESEARCH PROGRESS. THE SYMPOSIUM HAS CREATED A SYNERGISTIC RESEARCH COMMUNITY WORKING IN PARTNERSHIP WITH CRF.

Form 990s for Cystinosis Research Foundation

Fiscal year endingDate received by IRSFormPDF link
2020-062021-03-01990View PDF
2019-062020-08-14990View PDF
2018-062019-05-14990View PDF
2017-062018-08-17990View PDF
2016-122017-11-22990View PDF
...and 7 more Form 990s

Who funds Cystinosis Research Foundation

Grants from foundations and other nonprofits
GrantmakerDescriptionAmount
24 Hours for HankResearch$202,200
 View purchase optionsHealth$25,000
 View purchase optionsGeneral Support$15,545
...and 10 more grants received

Grants made by Cystinosis Research Foundation

GranteeGrant descriptionAmount
Regents of the University of California at San DiegoMedical Research$923,078
Massachusetts General HospitalMedical Research$317,121
Scripps Research InstituteMedical Research$150,000

Financials for Cystinosis Research Foundation

RevenuesFYE 06/2020
Total grants, contributions, etc.$4,064,820
Program services$0
Investment income and dividends$88,944
Tax-exempt bond proceeds$0
Royalty revenue$0
Net rental income$0
Net gain from sale of non-inventory assets$154,660
Net income from fundraising events$0
Net income from gaming activities$0
Net income from sales of inventory$0
Miscellaneous revenues$0
Total revenues$4,308,424

Personnel at Cystinosis Research Foundation

NameTitleCompensation
Zoe R. SolsbyVice President, Has Been
Geoffrey L. StackVice Chair$0
Nancy J. StackChair - Trustee$0
 View purchase optionsPresident$0

Organizations like Cystinosis Research Foundation

OrganizationLocationRevenue
Machine Tool Technologies Research FoundationSan Francisco, CA$1,202,524
Sanford Consortium For Regenerative MedicineLa Jolla, CA$8,138,446
Childhood Arthritis and Rheumatology Research AllianceMilwaukee, WI$11,029,270
The Chadtough FoundationSaline, MI$2,727,620
CLL Global Research FoundationHouston, TX$2,331,974
Michael Mosier Defeat Dipg FoundationPotomac, MD$1,832,127
Answer AlsMetairie, LA$1,360,589
The Brett Boyer FoundationNashville, TN$1,541,593
Metavivor Research and SupportAnnapolis, MD$5,661,985
Eastern Virginia Medical School (EVMS)Norfolk, VA$12,211,760
Jewish Heritage Fund for Excellence (JHFE)Louisville, KY$12,339,195
American Friends of Herzog HospitalNew York, NY$5,490,214
Childrens Hospital Foundation at Saint FrancisTulsa, OK$2,314,902
Christian Blind Mission InternationalWheaton, IL$8,104,908
Foundation for Angelman Syndrome TherapeuticsDowners Grove, IL$5,739,183
Agricultural Research FoundationCorvallis, OR$9,336,784
Broad Street Clinic FoundationMorehead City, NC$6,010,584
Pediatric Epilepsy Research Foundation (PERF)Dallas, TX$4,747,062
The National Cancer Coalition (NCC)Raleigh, NC$12,166,162
Mink Veterinary Consulting and ReseGlenbeulah, WI$3,581,731
Belgian American Educational Foundation (BAEF)New Haven, CT$13,151,511
The American Laryngological Rhinological and Otological SocietyOmaha, NE$2,333,738
Catholic Association FoundationWashington, DC$6,344,500
HarborPathCharlotte, NC$15,025,812
Siut North AmericaHouston, TX$2,511,249
Nonprofit Types
Issues
Characteristics
Key performance indicators
Total revenues
$4,308,424
2020
Yearly growth
-20.3%
% of revenues
n/a
Total expenses
$3,362,690
2020
Yearly growth
-42.7%
% of expenses
n/a
Total assets
$9,847,694
2020
Yearly growth
1.6%
% of assets
n/a
Num. employees
1
2020
Yearly growth
0%
% of total
n/a
General information
Address
19200 Von Karman Ave
Irvine, CA 92612
Metro area
Los Angeles-Long Beach-Anaheim, CA
County
Orange County, CA
Website URL
cystinosisresearch.org/ 
Phone
(949) 223-7610
IRS details
EIN
32-0067668
Fiscal year end
June
Taxreturn type
Form 990
Year formed
2003
Eligible to receive tax-deductible contributions (Pub 78)
Yes
Categorization
NTEE code, primary
H90: Medical Specialty Research
NAICS code, primary
813212: Health and Disease Research Fundraising Organizations
Parent/child status
Independent